Tirbanibulin — Active Pharmaceutical Ingredient

Tirbanibulin is an active pharmaceutical ingredient found in 1 FDA-approved drug product. Forms: OINTMENT. Routes: TOPICAL.

This content is for informational purposes only. Always consult a healthcare professional.

Tirbanibulin (1 brand name, 1 dosage form, 1 route)

Available dosage forms: OINTMENT.

Routes of administration: TOPICAL.

Brand Names

  • KLISYRI

Indications and Usage

KLISYRI is indicated for the topical field treatment of actinic keratosis on the face or scalp.

Dosage and Administration

For topical use only; not for oral or ophthalmic use. Apply KLISYRI evenly to cover up to 100 cm2 treatment field on the face or balding scalp once daily for 5 consecutive days using 1 unit-dose packet per application. Wash hands immediately with soap and water after application. Avoid washing and touching the treated area for approximately 8 hours after application of KLISYRI. Following this time, the area may be washed with a mild soap. Avoid transfer of KLISYRI to the periocular area [see Warnings and Precautions (5.1)]. Avoid application near and around the mouth and lips.

Contraindications

None.

Mechanism of Action

Tirbanibulin is a microtubule inhibitor. The mechanism of action of KLISYRI for the topical treatment of actinic keratosis is unknown.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.